MwanzoAJANTPHARM • NSE
add
Ajanta Pharma Ltd
Bei iliyotangulia
₹ 2,500.70
Bei za siku
₹ 2,472.30 - ₹ 2,511.60
Bei za mwaka
₹ 2,111.05 - ₹ 3,485.00
Thamani ya kampuni katika soko
310.76B INR
Wastani wa hisa zilizouzwa
elfu 82.74
Uwiano wa bei na mapato
33.83
Mgao wa faida
2.17%
Ubadilishanaji wa msingi
NSE
Habari za soko
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
| (INR) | Mac 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato | 11.70B | 11.04% |
Matumizi ya uendeshaji wa biashara | 6.35B | 31.66% |
Mapato halisi | 2.25B | 11.12% |
Kiwango cha faida halisi | 19.25 | 0.10% |
Mapato kwa kila hisa | 18.00 | 11.87% |
EBITDA | 2.88B | 1.99% |
Asilimia ya kodi ya mapato | 16.39% | — |
Taarifa ya Hali ya Kifedha
Jumla ya mali
Jumla ya dhima
| (INR) | Mac 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Uwekezaji wa pesa taslimu na vipindi vifupi | 6.15B | 33.82% |
Jumla ya mali | 50.15B | 8.12% |
Jumla ya dhima | 12.25B | 14.34% |
Jumla ya hisa | 37.90B | — |
hisa zilizosalia | 124.87M | — |
Uwiano wa bei na thamani | 8.24 | — |
Faida inayotokana na mali | — | — |
Faida inayotokana mtaji | 16.71% | — |
Mtiririko wa pesa
Mabadiliko halisi ya pesa taslimu
| (INR) | Mac 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato halisi | 2.25B | 11.12% |
Pesa kutokana na shughuli | — | — |
Pesa kutokana na uwekezaji | — | — |
Pesa kutokana na ufadhili | — | — |
Mabadiliko halisi ya pesa taslimu | — | — |
Mtiririko huru wa pesa | — | — |
Kuhusu
Ajanta Pharma Limited, also known by the acronym APL, is a multinational company based in India engaged in development, manufacturing, and marketing of pharmaceutical formulations. It has a presence in India, the United States, and about 30 other countries in Africa, South East Asia, West Asia, and CIS. It was established in 1973. Wikipedia
Ilianzishwa
1973
Tovuti
Wafanyakazi
8,073
